Evidence map›Paper›PMID 36625345›Full record

ArticleJCI insight2023

Mucociliary transport deficiency and disease progression in Syrian hamsters with SARS-CoV-2 infection.

Qian Li, Kadambari Vijaykumar, Scott E Phillips, Shah S Hussain, Nha V Huynh, Courtney M Fernandez-Petty, Jacelyn E Peabody Lever, Jeremy B Foote, Janna Ren, Javier Campos-Gómez and 16 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Optical Imaging of Cilia in the Head and Neck.Journal of clinical medicine · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Mucociliary clearance augmenting drugs block SARS-CoV-2 replication in human airway epithelial cells.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 6 institutions in 3 countries.

Qian LiDepartment of Medicine.
Kadambari VijaykumarDepartment of Medicine.
Scott E PhillipsDepartment of Medicine.
Shah S HussainDepartment of Medicine.
Nha V HuynhGraduate Biomedical Sciences Program.
Courtney M Fernandez-PettyDepartment of Medicine.
Jacelyn E Peabody LeverDepartment of Medicine.
Jeremy B FooteDepartment of Microbiology.
Janna RenDepartment of Chemistry.
Javier Campos-GómezDepartment of Medicine.
Farah Abou DayaDepartment of Medicine.
Nathaniel W HubbsDepartment of Medicine.
Harrison KimGregory Fleming James Cystic Fibrosis Research Center.
Ezinwanne OnuohaDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Evan R BoitetDepartment of Medicine.
Lianwu FuDepartment of Medicine.
Hui Min LeungWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Linhui YuWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Thomas W DetchemendyDepartment of Microbiology.
Levi T SchaefersDepartment of Microbiology.
Jennifer L TipperDepartment of Anesthesiology and Perioperative Medicine.
Lloyd J EdwardsDepartment of Biostatistics.
Sixto M LealDepartment of Microbiology.
Kevin S HarrodDepartment of Anesthesiology and Perioperative Medicine.
Guillermo J TearneyWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Steven M RoweDepartment of Medicine.
Cystic Fibrosis Foundation · USCzech Academy of Sciences, Institute of Microbiology · CZHarvard University · USCancer Research And Biostatistics · USInstitute of Biomedical Science · GBUniversity of Alabama at Birmingham · US

Funding

UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMIT GAGGAR · 2007 to 2026
$23.0M
Construction/SEBLAB/Regional Biocontainment LaboratoryUC6AI058599 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MARCHASE, RICHARD BANFIELD · 2003 to 2006
$22.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008361 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YACOUBIAN, TALENE ALENE · 1992 to 2024
$16.8M
Translational Program in CFTR-Related Airway DiseasesR35HL135816 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROWE, STEVEN MARK · 2017 to 2022
$6.3M
Training Program in Lung Biology and Translational MedicineT32HL105346 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GAGGAR, AMIT · 2010 to 2025
$5.0M
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal ImmunityR01AI170719 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Sixto Manuel Leal · 2023 to 2026
$2.9M
Influenza regulation of epithelial pneumococcal host defense.R01HL149944 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HARROD, KEVIN S · 2020 to 2023
$1.5M
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal ImmunityR56AI170719 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEAL, SIXTO MANUEL · 2022 to 2022
$668k
Mucus Matters: Mucociliary Physiology in Pulmonary FibrosisF31HL146083 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEVER, JACELYN EMILY PEABODY · 2019 to 2020
$77k
NHLBI NIH HHS F31 HL146083NHLBI NIH HHS R01 HL149944NHLBI NIH HHS R35 HL135816NHLBI NIH HHS T32 HL105346NIAID NIH HHS R01 AI170719NIAID NIH HHS R56 AI170719NIAID NIH HHS UC6 AI058599NIDDK NIH HHS P30 DK072482NIGMS NIH HHS T32 GM008361
6 · The paper itself

Abstract

Substantial clinical evidence supports the notion that ciliary function in the airways is important in COVID-19 pathogenesis. Although ciliary damage has been observed in both in vitro and in vivo models, the extent or nature of impairment of mucociliary transport (MCT) in in vivo models remains unknown. We hypothesize that SARS-CoV-2 infection results in MCT deficiency in the airways of golden Syrian hamsters that precedes pathological injury in lung parenchyma. Micro-optical coherence tomography was used to quantitate functional changes in the MCT apparatus. Both genomic and subgenomic viral RNA pathological and physiological changes were monitored in parallel. We show that SARS-CoV-2 infection caused a 67% decrease in MCT rate as early as 2 days postinfection (dpi) in hamsters, principally due to 79% diminished airway coverage of motile cilia. Correlating quantitation of physiological, virological, and pathological changes reveals steadily descending infection from the upper airways to lower airways to lung parenchyma within 7 dpi. Our results indicate that functional deficits of the MCT apparatus are a key aspect of COVID-19 pathogenesis, may extend viral retention, and could pose a risk factor for secondary infection. Clinically, monitoring abnormal ciliated cell function may indicate disease progression. Therapies directed toward the MCT apparatus deserve further investigation.

Indexed as

COVID-19AnimalsCricetinaeDisease Models, AnimalDisease ProgressionLungMesocricetusMucociliary ClearanceSARS-CoV-2Subgenomic RNASubgenomic RNACOVID-19Respiration

Identifiers

PMID36625345
PMCPMC9870055
OpenAlexW4315436324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.